274. I am pleased to join my colleagues from WHO and WTO and to add a few words on the second edition of the trilateral study. 275. Since the launch of the first edition of the study in 2013, considerable relevant work has been undertaken in WIPO that has informed the update of the study. 276. For example, comprehensive studies have been prepared for, and have been discussed in, the WIPO Standing Committee on the Law of Patents (SCP), particularly under the agenda item patents and health. These include studies on: The Role of Patent Systems in Promoting Innovative Medicines, and in Fostering the Technology Transfer necessary to Make Generic and Patented Medicines available in developing countries and least developed countries (SCP/21/8); Constraints faced by developing countries and least developed countries (LDCs) in making full use of Patent Flexibilities and their lmpacts on Access to Affordable Especially Essential Medicines for Public Health Purposes in those Countries: (SCP/26/5 and SCP/27/6); and the Feasibility Study on the Disclosure of International Non-proprietary Names (INN) in Patent Applications and/or Patents (SCP/21/9 and SCP/28/5). 277. The WIPO Global Innovation Index 2019 Creating Healthy Lives – The Future of Medical Innovation has informed the sections on economics of innovation and access to medical technologies. 278. At the same time, patent information systems have made significant progress and we now have much more sophisticated search tools to find relevant patent information, for instance through useful features in the WIPO Patentscope database. 279. The new WIPO Standard ST.27 (Recommendation for the exchange of patent legal status data) aims at improving worldwide availability, reliability and comparability of patent legal status data and we hope that the acceptance of this recommendation by patent offices leads to an improved understanding about patent legal status events across different jurisdictions. 280. There is, of course, much more in the study, such as updated and enhanced sections on copyright and trademarks. The study is comprehensive, and it takes a holistic perspective when it presents the intellectual property system in its health and trade contexts. Importantly, the study benefits from the expertise and close collaboration of the three Secretariats. 281. The COVID-19 pandemic requires that we stand together in solidarity and collaborate. The work done by the three Secretariats to produce this second edition is a small, and successful, instance of such collaboration. 282. We trust that this second edition of the trilateral study shall have many readers.